EDC for mobile health (mHealth) studies: ePRO, mobile data capture, and 21 CFR Part 11–aligned controls in one platform for smartphone- and app-based clinical research.
21 CFR Part 11 aligned · HIPAA-aligned security · No credit card required
The success of mHealth studies depends on participant engagement with mobile assessments. High ePRO completion rates are essential for data quality and statistical power. Low completion rates create missing data that can bias results and undermine the study’s scientific and regulatory value. Several design factors influence mHealth study engagement: the length and frequency of mobile assessments, the ease of the enrollment and login process, the clarity of the questionnaire interface, and the consistency of scheduling and reminders. Studies that require participants to download a specialized app, create an account, and navigate a complex interface face higher attrition and lower completion rates than those offering streamlined, web-based access. Capture’s ePRO design addresses these engagement factors. QR code enrollment allows participants to begin assessments without app installation—they scan a code and immediately access their study instruments in a mobile browser. The questionnaire interface is designed for mobile devices with clear layouts, progress indicators, and responsive design that works across phone sizes and operating systems. Skip logic ensures participants only see questions relevant to their responses, reducing assessment length and fatigue. For study teams, Capture provides ePRO completion tracking that identifies participants who have missed assessments. This visibility enables proactive outreach by coordinators before data gaps accumulate, supporting the retention and data completeness that mHealth studies require.
mHealth studies span a spectrum from fully remote (no in-person visits) to hybrid designs that combine clinical site visits with between-visit mobile data collection. The EDC system must support both extremes and everything in between. Fully remote mHealth studies use electronic consent delivered to the participant’s device, ePRO as the primary data collection method, and potentially telemedicine-based clinical assessments documented in CRFs. In these designs, Capture’s eConsent and ePRO modules serve as the study’s primary infrastructure: participants consent electronically, complete scheduled ePRO assessments, and never physically visit a study site. Hybrid designs—more common in interventional mHealth studies—combine periodic in-person visits (for screening, randomization, clinical assessments, and endpoint evaluation) with mobile ePRO collection between visits. Capture supports this naturally because ePRO and site-entered CRF data share the same platform, audit trail, and data model. There is no integration gap between the clinic-collected and mobile-collected portions of the study. For studies that evolve their design—moving from in-person consent to remote consent, adding mobile assessments mid-study, or reducing visit frequency based on interim analysis—Capture’s browser-based configuration allows protocol amendments to be implemented without vendor involvement or lengthy change control processes.
Regulatory agencies and ethics review boards are increasingly accepting—and even encouraging—mobile-collected data in clinical research. However, this acceptance depends on the data quality framework. Mobile-collected data that lacks audit trails, documented consent, and access controls is treated with skepticism by regulatory reviewers. Capture provides the data quality infrastructure that makes mHealth data regulatory-acceptable. Every ePRO response is timestamped, attributed to the authenticated participant, and recorded in the audit trail. Electronic consent with digital signatures documents participant agreement with the same rigor as traditional paper consent. Role-based access ensures that coordinators, investigators, and monitors can view data appropriate to their role without compromising the participant’s privacy. For mHealth studies generating data that will support regulatory submissions—IND safety data, pivotal trial endpoints, or post-market surveillance—these quality controls are not optional. By building mHealth studies on Capture from the start, study teams ensure that their mobile-collected data meets the same standards as their clinic-collected data, without retroactive quality remediation. For academic mHealth studies, the same quality framework strengthens publications by providing verifiable data provenance that peer reviewers can evaluate. This is particularly important as journals establish stricter standards for mobile health research data.
Overview
Mobile health (mHealth) studies leverage smartphones and mobile technologies to deliver interventions, collect data, or engage participants outside traditional clinical settings. These studies range from fully remote smartphone-based interventions to hybrid designs that combine in-clinic visits with mobile data collection between visits. The common thread is the participant’s mobile device as a primary interface for study engagement. For study teams, mHealth research creates specific data capture requirements. Patient-reported outcomes need to be collected on the participant’s own device at scheduled intervals—sometimes daily or multiple times per day. Consent must be obtained and documented electronically, often before the participant ever visits a study site. Clinical assessments during any in-person visits must integrate into the same dataset as the mobile-collected data. And the entire data collection process must maintain the audit trails and access controls that regulatory and ethics review boards expect. mHealth studies often struggle with the gap between consumer-friendly mobile data collection and clinical-trial-grade compliance. Consumer survey tools are easy for participants to use but lack the audit trails, electronic signatures, and data governance that clinical research requires. Enterprise EDC platforms have the compliance infrastructure but treat mobile data collection as an afterthought, requiring bolt-on ePRO vendors with their own contracts, timelines, and integration overhead. Capture bridges this gap with integrated EDC, eConsent, and ePRO in one platform. ePRO is delivered natively through mobile-responsive instruments that participants access on their smartphones. eConsent allows fully electronic enrollment with digital signatures. Clinical CRF data from in-person visits enters the same system. And 21 CFR Part 11–aligned controls with HIPAA-aligned security ensure the entire dataset—mobile-collected and clinic-collected—meets the compliance standards that IRBs, sponsors, and regulatory agencies expect.
The defining characteristic of mHealth studies is the shift of data collection from the clinical site to the participant’s environment. This shift has profound implications for study operations and data quality. When participants complete ePRO instruments on their own devices without coordinator oversight, the system must be clear, accessible, and reliable—a confusing interface leads to missed assessments, invalid responses, and data loss that cannot be recovered. Traditional mHealth data collection approaches create fragmentation. The consent may be captured on paper at a screening visit (or skipped for low-risk studies), ePRO data collected via a third-party app, clinical visit data entered in a separate EDC, and all three datasets reconciled manually or through custom integration. Each seam in this process is a source of operational burden, data integrity risk, and monitoring complexity. Capture eliminates these seams by providing one platform for the complete mHealth study workflow. Consent is electronic and documented in the same system. ePRO instruments are built with the same CRF builder used for clinical forms, ensuring consistent skip logic, validation, and audit trails. QR code enrollment allows participants to join the study and begin completing mobile assessments without coordinator-mediated app installation or account creation. And because all data flows into one dataset with one audit trail, monitoring and analysis proceed without cross-system reconciliation. For study teams running mHealth research—whether a fully remote study with no in-person visits or a hybrid design combining clinic and mobile data—this integrated approach reduces operational complexity and strengthens data integrity.
FAQ
Explore the platform with a free sandbox. No sales call required.
Explore platform